Remove Generic Drugs Remove Packaging Remove Trials
article thumbnail

Should we be worried about pharma’s supply chain?

World of DTC Marketing

Prescription and over-the-counter (OTC) medications originate in factories all over the world, moving into the American marketplace through supply chains that can involve numerous processing plants, manufacturers, suppliers, brokers, packagers, and distributors. Can patients really be confident in pharma supply chains?

article thumbnail

In the News: September 2021 Regulatory and Development Updates

Camargo

Continued development of the use of complex innovative trial designs. The sponsors of the accepted proposals will submit a full package consisting of required toxicology and quality data, as outlined in the Federal Register. Improved predictability in Human Factors and User-Related Risk reviews. Container-closure changes. Orientation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

A lower number of clinical trials and regulatory filings were other important influences behind the decision. Meanwhile, another recently released MHLW report confirmed that 696 essential drugs from 94 companies were identified as unprofitable due to increasing costs of manufacturing and packaging and the depreciation of the Japanese yen.

Marketing 173
article thumbnail

Five Trends in Contract Drug Manufacturing Organisations

Pharmaceutical Technology

Avéma, for example, specialises in small molecule, oral solid, and liquid dose drugs. generic drugs at both small development companies and multinational pharmaceutical companies. Avéma has also expanded its liquid manufacturing capabilities and added full on-site serialisation capabilities to its packaging lines.

article thumbnail

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

A lower number of clinical trials and regulatory filings were other important influences behind the decision. Meanwhile, another recently released MHLW report confirmed that 696 essential drugs from 94 companies were identified as unprofitable due to increasing costs of manufacturing and packaging and the depreciation of the Japanese yen.

Marketing 130
article thumbnail

Drug labeling authority, UDI program reviewed by Harvard-based researchers

The Pharma Data

The authority to change drug labels outside of considerations for new safety information “could encourage third parties, such as academic investigators, insurance companies, and cooperative trial groups, to initiate such changes,” they wrote. .

Drugs 52
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. 2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19. Other drugs also contributed to Merck’s revenue growth. Toujeo generated Sanofi €1.12

Sales 98